glp 1 drug novo nordisk With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins The GLP-1 Race - VERUS

Oral administration is typically preferred for gut-specific goals, though injectable can address both gut and systemic inflammation simultaneously

Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis

Many people live with low-grade chronic inflammation for years without realizing its the root cause of their ongoing physical challenges

This paper serves as a call to action for the food science community to embrace this paradigm shift and dedicate resources to further explore the vast, and largely untapped, potential of dietary hormesis

10.1016/S0006-291X(84)80190-4 148 GodoyL